Scientists showed in hepatocellular carcinoma (HCC) cells, xenografts, and patient-derived organoids that fasting improved sorafenib efficacy and acted synergistically to sensitize sorafenib-resistant HCC.
[Science Advances]
7992332
{7992332:BBBBBBBB}
apa
50
1
171135
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
